Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)

Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4): 425-427. doi:10.36849/JDD.7098.

Saved in:
Bibliographic Details
Published inJournal of drugs in dermatology Vol. 22; no. 4; p. 425
Main Authors Alsukait, Sarah, Learned, Christine, Rosmarin, David
Format Journal Article
LanguageEnglish
Published United States 01.04.2023
Subjects
Adult
Humans
Lupus Erythematosus, Discoid - diagnosis
Lupus Erythematosus, Discoid - drug therapy
Pilot Projects
Piperidines - adverse effects
Online AccessGet more information

Cover

More Information
Summary:Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4): 425-427. doi:10.36849/JDD.7098.
ISSN:1545-9616
DOI:10.36849/JDD.7098